Atypical Diffusion-Restricted Lesion in 5-Fluorouracil Encephalopathy

References

1. 1.↵
   1. Sioka C,
   2. Kyritsis AP

   . Central and peripheral nervous system toxicity of common chemotherapeutic agents. Cancer Chemother Pharmacol 2009;63:761–67

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Lucato LT,
   2. McKinney AM,
   3. Short J,
   4. et al

   . Reversible findings of restricted diffusion in 5-fluorouracil neurotoxicity. Australas Radiol 2006;50:364–68

   CrossRefPubMed
3. 3.↵
   1. Videnovic A,
   2. Semenov I,
   3. Chua-Adajar R,
   4. et al

   . Capecitabine-induced multifocal leukoencephalopathy: a report of five cases. Neurology 2005;65:1792–94, discussion 1685. Epub 2005 Oct 19

   Abstract/FREE Full Text
4. 4.↵
   1. Okada J,
   2. Yoshikawa K,
   3. Matsuo H,
   4. et al

   . Reversible MRI and CT findings in uremic encephalopathy. Neuroradiology 1991;33:524–26

   CrossRefPubMedWeb of Science
5. 5.↵
   1. van Kuilenburg AB

   . Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil. Eur J Cancer 2004;40:939–50

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Brusilow SW

   . Hyperammonemic encephalopathy. Medicine (Baltimore) 2002;81:240–49

   CrossRefPubMed
7. 7.↵
   1. Chue AL,
   2. Fernando IN,
   3. Hussain SA,
   4. et al

   . Chemotherapy related encephalopathy in a patient with stage IV cervical carcinoma treated with cisplatin and 5-fluorouracil: a case report. Cases J 2009;2:8526

   CrossRefPubMed